MCK
MCKESSON CORP
-8.77 (-0.99%)878.52USD176K成交股數102B市值23.6本益比(近四季)0.3股價營收比+7.7%營收年增(近四季)2026-11-04下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 3 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 27Q1 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 105B+16% | 106B+11% | 103B+10% | 97.8B+23% | 90.8B+12% | 95.3B+23% | 93.7B+26% | 79.3B+15% | 80.9B | 77.2B | 74.5B | 68.9B |
| 營業成本 | 102B | 102B | 99.6B | 94.5B | 87.2B | 92.0B | 90.4B | 76.1B | 77.7B | 74.1B | 71.5B | 65.8B |
| 毛利 | 3.7B+1% | 3.7B+12% | 3.5B+9% | 3.3B+4% | 3.6B+15% | 3.3B+7% | 3.2B+7% | 3.2B+3% | 3.2B | 3.1B | 3.0B | 3.1B |
| 毛利率 | 3.5% | 3.5% | 3.4% | 3.4% | 4.0% | 3.4% | 3.5% | 4.0% | 3.9% | 4.0% | 4.1% | 4.4% |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 2.3B | 2.0B | 2.1B | 2.2B | 2.0B | 2.0B | 2.5B | 2.0B | 2.5B | 2.1B | 1.9B | 2.0B |
| 營業利益 | 1.3B-17% | 1.6B+32% | 1.4B+143% | 1.0B+1% | 1.6B+148% | 1.2B+29% | 578M-47% | 1.0B+5% | 642M | 951M | 1.1B | 980M |
| 營業利益率 | 1.3% | 1.5% | 1.4% | 1.1% | 1.8% | 1.3% | 0.6% | 1.3% | 0.8% | 1.2% | 1.5% | 1.4% |
| 稅後淨利 | 614M-51% | 1.2B+35% | 1.1B+361% | 784M-14% | 1.3B+114% | 879M+32% | 241M-75% | 915M+16% | 589M | 664M | 958M | 787M |
| 淨利率 | 0.6% | 1.1% | 1.1% | 0.8% | 1.4% | 0.9% | 0.3% | 1.2% | 0.7% | 0.9% | 1.3% | 1.1% |
| 稀釋 EPS | 5.15-48% | 9.59+38% | 8.92+377% | 6.25-11% | 9.90+124% | 6.95+41% | 1.87-73% | 7.00+23% | 4.42 | 4.92 | 7.02 | 5.69 |
| 稀釋股數 | 119M | 124M | 124M | 126M | 128M | 127M | 129M | 131M | 133M | 135M | 137M | 142M |
資產負債表 期末餘額
| 科目 | 27Q1 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 5.2B | 3.0B | 4.0B | 2.4B | 5.7B | 1.1B | 2.5B | 2.3B | 2.0B | 2.5B | 2.6B | 4.7B |
| 應收帳款 | 30.3B | 28.2B | 28.3B | 28.2B | 25.6B | 25.8B | 25.3B | 23.7B | 23.1B | 22.5B | 21.9B | 19.4B |
| 存貨 | 26.3B | 27.1B | 26.1B | 25.1B | 23.0B | 23.8B | 24.2B | 25.6B | 22.0B | 21.9B | 20.5B | 19.7B |
| 總資產 | 88.3B | 84.2B | 84.2B | 81.3B | 75.1B | 71.1B | 72.4B | 71.7B | 66.5B | 66.1B | 64.1B | 62.3B |
| 有息負債 | 9.7B | 6.6B | 7.8B | 7.8B | 5.7B | 5.6B | 5.7B | 5.6B | 5.7B | 5.6B | 5.7B | 5.6B |
| 總負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 股東權益 | −4.2B | −1.3B | −1.7B | −2.0B | −2.1B | −3.1B | −3.0B | −1.8B | −2.1B | −1.8B | −1.6B | −1.9B |
| 負債比 | – | – | – | – | – | – | – | – | – | – | – | – |
| 淨現金(現金 − 有息負債) | −4.6B | −3.6B | −3.8B | −5.4B | 37.0M | −4.5B | −3.2B | −3.3B | −3.7B | −3.1B | −3.0B | −916M |
現金流量表 單季
| 科目 | 27Q1 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | −220M | – | – | −918M-33% | – | – | – | −1.4B | – | – | −1.1B | – |
| 資本支出 | 112M | – | – | 111M | – | – | – | 106M | – | – | 78.0M | – |
| 自由現金流 | −332M | – | – | −1.0B-31% | – | – | – | −1.5B | – | – | −1.1B | – |
| 折舊攤銷 | 195M | 188M | 188M | 157M | −213M | 153M | 163M | 169M | – | – | – | – |
| 買回庫藏股 | 2.5B | – | – | 581M | – | – | – | 527M | – | – | 696M | – |
| 現金股利 | 102M | – | – | 90.0M | – | – | – | 82.0M | – | – | 74.0M | – |
| 自由現金流率 | -0.3% | – | – | -1.1% | – | – | – | -1.9% | – | – | -1.5% | – |
營收拆解 2026 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2026 年度 · 402B
| North American Pharmaceutical | 337B | 83.7% | +10.6% |
|---|---|---|---|
| Oncology And Multispecialty | 48.4B | 12.0% | +31.4% |
| Medical Surgical Solutions | 11.5B | 2.9% | +1.1% |
| Prescription Technology Solutions | 5.8B | 1.4% | +11.3% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2026 | 403B | +12.4% | 4.8B | 1.2% | 38.38 | 5.7B |
| FY2025 | 359B | +16.2% | 3.3B | 0.9% | 25.72 | 5.5B |
| FY2024 | 309B | +11.7% | 3.0B | 1.0% | 22.39 | 3.9B |
| FY2023 | 277B | +4.8% | 3.6B | 1.3% | 25.03 | 4.8B |
| FY2022 | 264B | +10.8% | 1.1B | 0.4% | 7.23 | 4.0B |
| FY2021 | 238B | +3.1% | −4.5B | -1.9% | -28.26 | 4.1B |
| FY2020 | 231B | +7.8% | 900M | 0.4% | 4.95 | 4.0B |
| FY2019 | 214B | – | 34.0M | 0.0% | 0.17 | 3.6B |